Molecular testing, built for providers.
Fast, accurate diagnostics backed by a lab team that treats every sample like it matters, because it does.
Start a Trial →PCR vs. Culture
PCR detects what culture & Next Gen Sequencing miss. Get results in 24 to 48 hours vs 3 to 14 days.
Syndromic Test Menu
Comprehensive panels spanning respiratory, UTI, genitourinary, wound, and FDA sexual health infections.
Antibiotic Stewardship
Reduce broad-spectrum antibiotic overuse with targeted, pathogen-specific results and resistance gene detection.
Personalized Antibiogram
Every report includes a results-specific antibiogram so providers can choose the most targeted antibiotic from the start.
One-page results, built for clinical decisions.
Our molecular PCR report gives providers a complete clinical picture on a single page, from pathogen detection to targeted treatment options.
Hover a feature to see it on the report Tap a number to highlight it on the report below
-
1
↓
1-Page Summary Report
Patient info, detected pathogens, and treatment guidance all on the first page. No hunting, no second-guessing.
-
2
↓
Pathogen Identification
Detected organisms listed by type and result status. PCR catches co-infections and fastidious organisms that traditional culture routinely misses.
-
3
↓
Antibiotic Resistance Genes
Resistance genes are flagged directly on the report, giving providers the insight they need to avoid ineffective treatments before they start.
-
4
↓
Personalized Antibiogram
A results-specific antibiotic effectiveness table built on Sanford Guide recommendations. Choose the most targeted, non-broad-spectrum treatment fast.
Pathogens detected. Patients, protected.
PCR-based infectious disease testing gives providers the pathogen-specific answers they need to eliminate broad-spectrum treatments and make targeted clinical decisions faster.
Specimen logistics, simplified.
From the moment supplies arrive at your office to the moment your specimens reach our lab, every step is on us.
Testing that protects your patients.
Infectious disease testing is more than a diagnostic tool. It's how providers prescribe smarter, reduce resistance, and keep patients safe.
2.8 million antibiotic-resistant infections occur in the U.S. each year.1
Nearly 1 in 3 antibiotic prescriptions in outpatient settings is unnecessary.2
More than 35,000 Americans die each year from antibiotic-resistant infections.1
Sources: 1 Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2019. U.S. Department of Health and Human Services, CDC; 2019. 2 Fleming-Dutra KE, et al. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010–2011. JAMA. 2016;315(17):1864–1873.
Targeted Treatment
PCR identifies the exact pathogen so providers prescribe the right antibiotic the first time.
Faster Clinical Decisions
Results in 24 to 48 hours eliminate the guesswork of empiric therapy and improve patient outcomes.
Antibiotic Stewardship
Accurate syndromic testing reduces unnecessary prescriptions and helps combat resistance at the community level.
Tap a Region.Exploreyour test panel.
Respiratory PCR Panels
- Adenovirus
- Coronavirus (229E, HKU1, NL63, OC43)
- COVID-19 Coronavirus (SARS-CoV-2)
- Cytomegalovirus
- Enterovirus D68
- Human metapneumovirus
- Influenza virus A, B
- Parainfluenza virus (types 1, 2, 3, 4)
- Respiratory syncytial virus
- Rhinovirus / Enterovirus
- Aspergillus spp. (flavus, niger, terreus, fumigatus)
- Candida albicans, parapsilosis, tropicalis
- Candida glabrata
- Acinetobacter baumannii
- Bordetella pertussis, parapertussis, bronchiseptica
- Chlamydia pneumoniae
- Enterobacter cloacae complex / Klebsiella aerogenes
- Escherichia coli
- Haemophilus influenzae
- Klebsiella oxytoca
- Klebsiella pneumoniae
- Legionella pneumophila
- Moraxella catarrhalis
- Mycoplasma pneumoniae
- Nocardia spp.
- Proteus mirabilis, vulgaris
- Pseudomonas aeruginosa
- Serratia marcescens
- Staphylococcus aureus
- Streptococcus agalactiae (Group B)
- Streptococcus pneumoniae
- ACT/MIR, FOX, ACC Groups
- CTX-M Groups
- DfrA1, DfrA5, Sul1, Sul2, Sul3
- ermA, ermB, ermC, metA
- IMP, NDM, VIM Groups
- mecA, mecC
- OXA48, OXA51
- gyrA1/A2, gyrB2, gyrS
- SHV, KPC Groups
- tetB, tetM
- vanA, vanB
- Adenovirus
- Coronavirus (229E, HKU1, NL63, OC43)
- COVID-19 Coronavirus (SARS-CoV-2)
- Enterovirus D68
- Epstein-Barr Virus
- HSV Type 1 & 2
- Human metapneumovirus
- Influenza virus A, B
- Parainfluenza virus (types 1, 2, 3, 4)
- Respiratory syncytial virus
- Rhinovirus / Enterovirus
- Candida albicans, parapsilosis, tropicalis
- Candida glabrata
- Chlamydia pneumoniae
- Fusobacterium nucleatum / Fusobacterium necrophorum
- Mycoplasma pneumoniae
- Streptococcus dysgalactiae subsp. equisimilis
- Streptococcus pyogenes (Group A)
- ACT/MIR, FOX, ACC Groups
- CTX-M Groups
- DfrA1, DfrA5, Sul1, Sul2, Sul3
- ermA, ermB, ermC, metA
- IMP, NDM, VIM Groups
- mecA, mecC
- OXA48, OXA51
- gyrA1/A2, gyrB2, gyrS
- SHV, KPC Groups
- tetB, tetM
- vanA, vanB
- Aspergillus spp. (flavus, niger, terreus, fumigatus)
- Candida albicans, parapsilosis, tropicalis
- Candida glabrata
- Fusobacterium nucleatum / Fusobacterium necrophorum
- Haemophilus influenzae
- Moraxella catarrhalis
- Nocardia spp.
- Pseudomonas aeruginosa
- Staphylococcus aureus
- Streptococcus pneumoniae
- ACT/MIR, FOX, ACC Groups
- CTX-M Groups
- DfrA1, DfrA5, Sul1, Sul2, Sul3
- ermA, ermB, ermC, metA
- IMP, NDM, VIM Groups
- mecA, mecC
- OXA48, OXA51
- gyrA1/A2, gyrB2, gyrS
- SHV, KPC Groups
- tetB, tetM
- vanA, vanB
- Adenovirus
- Coronavirus (229E, HKU1, NL63, OC43)
- COVID-19 Coronavirus (SARS-CoV-2)
- Enterovirus D68
- Human metapneumovirus
- Influenza virus A, B
- Parainfluenza virus (types 1, 2, 3, 4)
- Respiratory syncytial virus
- Influenza A and B
- Respiratory Syncytial Virus
- SARS-CoV-2
Wound PCR Panel
- Varicella-Zoster Virus
- Herpes simplex virus 1
- Herpes simplex virus 2
- Candida albicans, glabrata, parapsilosis, tropicalis
- Escherichia coli
- Pseudomonas aeruginosa
- Serratia marcescens
- Staphylococcus aureus
- Streptococcus agalactiae (Group B Strep)
- Streptococcus pyogenes (Group A Strep)
- Enterobacter cloacae, Klebsiella (Enterobacter) aerogenes
- Vibrio cholerae, parahaemolyticus, vulnificus
- Bacteroides fragilis, Fusobacteria vulgatus
- Klebsiella pneumoniae, oxytoca
- Proteus mirabilis, vulgaris
- VanA, VanB
- mecA
- ermB, C; mefA
- gyrA1, A2, B2
- tet B, tet M
- SHV, KPC Groups
- CTX-M Groups
- IMP, NDM, VIM Groups
- ACT, MIR, FOX, ACC Groups
- OXA Groups
- gfr (A1, A5), sul (1, 2)
Genitourinary PCR Panels
- Trichomonas vaginalis
- Candida albicans, parapsilosis, tropicalis
- Candida glabrata
- Candida krusei
- Acinetobacter baumannii
- Citrobacter freundii
- Enterobacter cloacae complex
- Enterococcus faecalis
- Enterococcus faecium
- Escherichia coli
- Klebsiella aerogenes
- Klebsiella oxytoca
- Klebsiella pneumoniae
- Morganella morganii
- Mycoplasma genitalium
- Mycoplasma hominis
- Neisseria gonorrhoeae
- Proteus mirabilis
- Pseudomonas aeruginosa
- Serratia marcescens
- Staphylococcus epidermidis, haemolyticus, ludgunensis
- Staphylococcus saprophyticus
- Streptococcus agalactiae (Group B)
- Streptococcus pyogenes (Group A)
- Ureaplasma parvum
- Ureaplasma urealyticum
- ACT/MIR, FOX, ACC Groups
- CTX-M Groups
- DfrA1, DfrA5, Sul1, Sul2, Sul3
- ermA, ermB, ermC, metA
- IMP, NDM, VIM Groups
- mecA, mecC
- OXA48, OXA51
- gyrA1/A2, gyrB2, gyrS
- SHV, KPC Groups
- tetB, tetM
- vanA, vanB
- Candida albicans, parapsilosis, tropicalis
- Candida glabrata
- Candida krusei
- Acinetobacter baumannii
- Citrobacter freundii
- Enterobacter cloacae complex
- Enterococcus faecalis
- Enterococcus faecium
- Escherichia coli
- Klebsiella aerogenes
- Klebsiella oxytoca
- Klebsiella pneumoniae
- Morganella morganii
- Proteus mirabilis
- Proteus vulgaris
- Pseudomonas aeruginosa
- Serratia marcescens
- Staphylococcus aureus
- Staphylococcus epidermidis, haemolyticus, ludgunensis
- Staphylococcus saprophyticus
- Streptococcus agalactiae (Group B)
- Streptococcus pyogenes (Group A)
- ACT/MIR, FOX, ACC Groups
- CTX-M Groups
- DfrA1, DfrA5, Sul1, Sul2, Sul3
- ermA, ermB, ermC, metA
- IMP, NDM, VIM Groups
- mecA, mecC
- OXA48, OXA51
- gyrA1/A2, gyrB2, gyrS
- SHV, KPC Groups
- tetB, tetM
- vanA, vanB
- Trichomonas vaginalis
- Herpes simplex virus Type 1 & 2
- HPV Types 16 and 18
- Candida albicans, parapsilosis, tropicalis
- Candida glabrata (Nakaseomyces glabrata)
- Candida krusei (Pichia kudriavzevii)
- Atopobium vaginae
- BVAB 2, 3 (bacterial vaginosis associated bacteria)
- Chlamydia trachomatis
- Gardnerella vaginalis
- Megasphaera (types 1, 2)
- Mobiluncus spp.
- Mycoplasma genitalium
- Mycoplasma hominis
- Neisseria gonorrhoeae
- Ureaplasma parvum
- Ureaplasma urealyticum
- ACT/MIR, FOX, ACC Groups
- CTX-M Groups
- DfrA1, DfrA5, Sul1, Sul2, Sul3
- ermA, ermB, ermC, metA
- IMP, NDM, VIM Groups
- mecA, mecC
- OXA48, OXA51
- gyrA1/A2, gyrB2, gyrS
- SHV, KPC Groups
- tetB, tetM
- vanA, vanB
- Herpes simplex virus 1 & 2
- HPV Types 16 and 18
- Trichomonas vaginalis
- Chlamydia trachomatis
- Mycoplasma genitalium
- Mycoplasma hominis
- Neisseria gonorrhoeae
- Ureaplasma parvum
- Ureaplasma urealyticum
- VanA, VanB
- mecA
- ermB, C; mefA
- gyrA1, A2, B2
- tet B, tet M
- SHV, KPC Groups
- CTX-M Groups
- IMP, NDM, VIM Groups
- ACT, MIR, FOX, ACC Groups
- OXA Groups
- gfr (A1, A5), sul (1, 2)
Your local molecular lab. Always within reach.
Join hundreds of providers across the country who trust Southwest Labs for their toxicology and infectious disease testing needs.